跳到正文
原文
Albert Bourla· @AlbertBourla · X·· 6 天前AI 评分12
AI 导读

辉瑞CEO Albert Bourla 表示认同 Anthropic CEO Dario Amodei 对 AI 加速医学进步的乐观判断,并称辉瑞从药物发现到生产已见成效。但他强调,识别有前景的分子只是开始,药物安全有效必须经患者中严谨试验验证,需经验丰富的研究者和医生参与。他认为 AI 的速度与科学纪律结合,患者将比许多人预期更早受益。

正文

Share Dario’s optimism. AI is changing the pace of medical progress, and in our industry time is life. Already seeing this across @Pfizer from discovery to manufacturing.

But as a scientist I also know how humbling biology can be. Identifying a promising molecule is just the beginning. The only way to know if a medicine is safe and effective is careful, rigorous testing in patients. That takes time, and needs experienced researchers and physicians in the loop.

The future I see is AI’s speed and scientific discipline working together. If we get that right, patients will benefit sooner than many expect.

引用Yahoo Finance@YahooFinance
Anthropic CEO Dario Amodei thinks cancer, Alzheimer’s, heart disease, and mental illness will be “relics of the past” in less than a decade, thanks to AI.
在 X 查看被引用的帖子

来源:Albert Bourla · x.com